In the past 52-week period, shares of AVEO Pharmaceuticals, Inc. (NASDAQ:AVEO) have moved within the range of $0.50 to $4.24. On the stock’s most recent trading day, the company’s shares ended the regular session at $2.70, which is 36.32% higher than its 52-week high.
AVEO Pharmaceuticals, Inc. (AVEO) has demonstrated a 20-day simple moving average (SMA) of -9.68%, and a 50-day SMA of -16.22%. This public company’s current market capitalization stands at $324.84 million.Analyzing Consensus Estimates, Sales Revenue and Net Income
Gauging the level of enthusiasm that Wall Street analysts have for a particular stock is important when considering an investment. According to the latest data, the consensus recommendation for AVEO Pharmaceuticals, Inc. (AVEO) is Outperform.
When it comes to reporting sales figures, public companies typically post earnings and revenue that fall above or below the average Wall Street forecast. In the most recent quarterly financial report, for the quarter ending Sep. 2017, AVEO Pharmaceuticals, Inc. (AVEO) delivered a 16.11% surprise with its net revenue.
Meanwhile, during the same quarter AVEO Pharmaceuticals, Inc. (AVEO) delivered a -340.00% earnings surprise. Net earnings for the quarter were posted at -$0.22 per share, whereas Wall Street had forecast -$0.05 per share.Ownership at AVEO Pharmaceuticals, Inc. (AVEO), According to Most Recent SEC Filings
A publicly-traded company’s most recent 13F filings give us important details about the organization’s institutional ownership. AVEO Pharmaceuticals, Inc. (AVEO) has 0 billion shares outstanding currently, 50.95% of which belong to institutional investors. Those institutional holdings amount to $0.17 billion.
Additionally, according to the most recent 13F filing from AVEO Pharmaceuticals, Inc. (AVEO), there were 19 new positions totaling 5,565,669 shares of the company’s stock. There were 9 sold out positions, on the other hand, totaling 4,202,593 shares.Short, Medium and Long Term Indicators
Taking a look at a stock’s average volume – in the long, medium and short terms – is helpful for understanding investor sentiment and trading activity. AVEO Pharmaceuticals, Inc. (AVEO) has had a 20-day average volume of 1,622,070 shares, with an average of 100% of short term indicators pointed at Sell.
The stock’s 50-day average volume has been 2,426,000 shares, with an average of 100% of medium term indicators pointing toward Sell. Finally, its 100-day average volume is 3,824,701 shares with 33% of long-term indicators pointing to Sell.